Why India needs more research-based life sciences companies

Is the Indian generic pharmaceutical industry one of the major obstacles to fighting endemic health problems in the country? You may begin to think so after reading this article written by Kiran Mazumdar-Shaw in the Economic Times. Ms Mazmudar-Shaw…

Get unlimited access to all IAM content